Primary vs. Secondary neoplasia-associated chromosomal abnormalities - Balanced rearrangements vs. Genomic imbalances?

Genes Chromosomes and Cancer

Volumn 16, Issue 3, 1996, Pages 155-163

  Johansson, Bertil ^a   Mertens, Fredrik ^a   Mitelman, Felix ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CYTOGENETICS; EPITHELIUM TUMOR; GENE REARRANGEMENT; GENOME; HUMAN; KARYOTYPE; LEUKEMIA; LYMPHOMA; MESENCHYMOMA; NEOPLASM; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; GENE REARRANGEMENT; GENOME, HUMAN; HUMANS; MODELS, GENETIC; NEOPLASMS;

EID: 0029902171     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199607)16:3<155::AID-GCC1>3.0.CO;2-Y     Document Type: Article

References (79)

1. Adams JM, Cory S (1992) Oncogene co-operation in leukaemogenesis. Cancer Surveys 15:119-141.
2. Armitage JO, Sanger WG, Weisenburger DD, Harrington DS, Linder J, Bierman PJ, Vose JM, Purtilo DT (1988) Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21). J Natl Cancer Inst 80:576-580.
3. Ayscue LH, Ross DW, Ozer H, Rao K, Gulley ML, Dent GA (1990) Bcr/abl recombinant DNA analysis versus karyotype in the diagnosis and therapeutic monitoring of chronic myeloid leukemia. Am J Clin Pathol 94:404-409.
4. Bernstein R, Gale RP (1990) Do chromosome abnormalities determine the type of acute leukemia that develops in CML? Leukemia 4:65-68.
5. Bower M, Parry P, Carter M, Lillington DM, Amess J, Lister TA, Evans G, Young BD (1994) Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. Blood 84:3776-3780.
6. Caligiuri MA, Schichman SA, Strout MP, Mrozek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM, Bloomfield CD (1994) Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res 54:370-373.
7. Campell LJ, Challis J, Fok T, Garson OM (1991) Chromosome 16 abnormalities associated with myeloid malignancies. Genes Chromosom Cancer 3:55-61.
8. Cleary ML (1991) Oncogenic conversion of transcription factors by chromosomal translocations. Cell 66:619-622.
9. Cortes JE, Kantarjian H, O'Brien S, Keating M, Pierce S, Freireich EJ, Estey E (1995) Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes. Leukemia 9:115-117.
10. Dobrovic A, Morley AA, Seshadri R, Januszewicz EH (1991) Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: Clinical features and course of M-bcr negative and M-bcr positive CML. Leukemia 5:187-190.
11. Dubé I, Dixon J, Beckett T, Grossman A, Weinstein M, Benn P, McKeithan T, Norman C, Pinkerton P (1989) Location of breakpoints within the major breakpoint cluster region (bcr) in 33 patients with bcr rearrangement-positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes. Genes Chromosom Cancer 1:106-111.
12. Estey E, Keating MJ, Pierce S, Stass S (1995) Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia. Leukemia 9:972-976.
13. Farber E, Rubin H (1991) Cellular adaptation in the origin and development of cancer. Cancer Res 51:2751-2761.
14. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 51:759-767.
15. Fenaux P, Lai JL, Preudhomme C, Jouet JP, Deminatti M, Bauters F (1990) Is translocation (8;21) a "favorable" cytogenetic rearrangement in acute myeloid leukemia? Nouv Rev Fr Hematol 33:179-182.
16. Ganesan TS, Rassool F, Guo AP, Th'ng KH, Dowding C, Hibbin JA, Young BD, White H, Kumaran TO, Galton DAG, Goldman JM (1986) Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia. Blood 68:967-960.
17. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266:1821-1828.
18. Heim S (1992) Is cancer cytogenetics reducible to the molecular genetics of cancer cells? Genes Chromosom Cancer 5:188-196.
19. Heim S, Mitelman F (1989) Primary chromosome abnormalities in human neoplasia. Adv Cancer Res 52:1-43.
20. Heim S, Mitelman F (1995) Cancer Cytogenetics, 2nd ed. New York: Wiley-Liss.
21. Heim S, Mandahl N, Mitelman F (1988) Genetic convergence and divergence in tumor progression. Cancer Res 48:5911-5916.
22. Hiorns LR, Min T, Swansbury GJ, Zelent A, Dyer MJS, Catovsky D (1994) Interstitial insertion of retinoic acid receptor-α gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood 83:2946-2951.
23. Höglund M, Johansson B, Pedersen-Bjergaard J, Marynen P, Mitelman F (1996) Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 87:324-330.
24. Ikeda K, Sasaki K, Tasaka T, Nagai M, Kawanishi K, Takahara J, Irino S (1994) Detection of PML-retinoic acid receptor-α fusion transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17). Am J Hematol 45:212-216.
25. H translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res 55:2876-2882.
26. Jin Y, Mertens F, Jin C, Åkervall J, Wennerberg J, Gorunova L, Mandahl N, Heim S, Mitelman F (1995) Nonrandom chromosome abnormalities in short-term cultured primary squamous cell carcinomas of the head and neck. Cancer Res 55:3204-3210.
27. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F (1993) Trisomy 7 in nonneoplastic cells. Genes Chromosom Cancer 6:199-205.
28. Johansson B, Mertens F, Mitelman F (1994) Secondary chromosomal abnormalities in acute leukemias. Leukemia 8:953-962.
29. Johansson B, Mertens F, Mitelman F (1995) Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 86:3905-3914.
30. Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ (1987) Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 83: 445-454.
31. Kobayashi H, Montgomery KT, Bohlander SK, Adra CN, Lim BL, Kucherlapati RS, Donis-Keller H, Holt MS, Le Beau MM, Rowley JD (1994) Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 84:3473-3482.
32. Kuss BJ, Deeley RG, Cole SPC, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA, Callen DF (1994) Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in the chromosome 16: Prognostic implications. Lancet 343:1531-1534.
33. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJB, Schuuring E, Kluin PM (1995) Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528-2536.
34. Liu Y, Hernandez AM, Shibata D, Cortopassi GA (1994) BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 91:8910-8914.
35. Mandahl N, Mertens F, Åman P, Rydholm A, Brosjö O, Willén H, Mitelman F (1994) Nonrandom secondary chromosome aberrations in liposarcomas with t(12;16). Int J Oncol 4:307-310.
36. Mandahl N, Limon J, Mertens F, Nedoszytko B, Gibas Z, Denis A, Willén H, Rydholm A, Szadowska A, Kreicbergs A, Rys J, Debiec-Rychter M, Mitelman F (1995) Nonrandom secondary chromosome aberrations in synovial sarcomas with t(X;18). Int J Oncol 7:495-499.
37. Mareni C, Sessarego M, Origone P, Defferrari R, Frassoni F, Ajmar F (1989) Molecular analysis of Philadelphia-negative myeloproliferative syndromes with i(17q). Cancer Genet Cytogenet 43:195-201.
38. Marlton P, Claxton DF, Liu P, Estey EH, Beran M, Le Beau MM, Testa JR, Collins FS, Rowley JD, Siciliano MJ (1995a) Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood 85:772-779.
39. Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E (1995b) Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia 9:965-971.
40. + CML and chronic myelomonocytic leukemia. Blood 78:205-211.
41. Maseki N, Miyoshi H, Shimizu K, Homma C, Ohki M, Sakurai M, Kaneko Y (1993) The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood 81:1573-1579.
42. Mitelman F (1993) The cytogenetic scenario of chronic myeloid leukemia. Leukemia Lymphoma 11:11-15.
43. Mitelman F (1994) Catalog of Chromosome Aberrations in Cancer, 5th ed. New York: Wiley-Liss.
44. Mitelman F, Kaneko Y, Berger R (1994) Report of the committee on chromosome changes in neoplasia. In Cuticchia AJ, Pearson PL (eds): Human Gene Mapping 1993. Baltimore: The Johns Hopkins University Press, pp 773-812.
45. Mitelman F, Kaneko Y, Berger R (1995) Report of the committee on chromosome changes in neoplasia. In Cuticchia AJ (ed): Human Gene Mapping 1994. Baltimore: The Johns Hopkins University Press, pp 955-961.
46. Morris CM, Fitzgerald PH, Hollings PE, Archer SA, Rosman I, Beard MEJ, Heaton DC, Newhook CJ (1988) Essential thrombocythaemia and the Philadelphia chromosome. Br J Haematol 70:13-19.
47. Mugneret F, Lizard S, Aurias A, Turc-Carel C (1988) Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16). Cancer Genet Cytogenet 32:239-245.
48. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23-28.
49. Nowell PC (1989) Chromosomal and molecular clues to tumor progression. Semin Oncol 16:116-127.
50. Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW (1994) Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia 8:1533-1538.
51. O'Brien S, Kantarjian HM, Keating M, Gagnon G, Cork A, Trujillo J, McCredie KB (1989) Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosomes 8 and 21. J Clin Oncol 7:1081-1086.
52. Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RSK (1991) Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosom Cancer 3:189-201.
53. Ohno H, Kerckaert JP, Bastard C, Fukuhara S (1994) Heterogeneity in B-cell neoplasms associated with rearrangement of the LAZ3 gene on chromosome band 3q27. Jpn J Cancer Res 85:592-600.
54. O'Malley FM, Garson OM (1985) Chronic granulocytic leukemia: Correlation of blastic transformation type with karyotypic evolution. Am J Hematol 20:313-323.
55. Onodera N, McCabe NR, Rubin CH (1992) Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. Blood 80:203-208.
56. Parreira L, Kearney L, Rassool F, Babapulle VB, Matutes E, Parreira A, Tavares de Castro J, Goldman JM, Catovsky D (1986) Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL. Cancer Genet Cytogenet 22:29-34.
57. Poirel H, Radford-Weiss I, Rack K, Troussard X, Veil A, Valensi F, Picard F, Guesnu M, Leboeuf D, Melle J, Dreyfus F, Flandrin G, Macintyre E (1995) Detection of the chromosome 16 CBFβ-MYH11 fusion transcript in myelomonocytic leukemias. Blood 85:1313-1322.
58. Prehn RT (1994) Cancers beget mutations versus mutations beget cancers. Cancer Res 54:5296-5300.
59. Rabbitts TH (1991) Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67:641-644.
60. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372:143-149.
61. Richardson ME, Quanguang C, Filippa DA, Offit K, Hampton A, Koduru PRK, Jhanwar SC, Lieberman PH, Clarkson BD, Chaganti RSK (1987) Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. Blood 70:444-447.
62. Rodriguez E, Sreekantaiah C, Chaganti RSK (1994) Genetic changes in epithelial solid neoplasia. Cancer Res 54:3398-3406.
63. Rubin H (1985) Cancer as a dynamic developmental disorder. Cancer Res 45:2935-2942.
64. Russo C, Carroll A, Kohler S, Borowitz M, Amylon M, Homans A, Kedar A, Shuster J, Land V, Crist W, Pullen J, Link M (1991) Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: A pediatric oncology group study. Blood 77:1050-1056.
65. 1-positive chronic myeloid leukemia. Blood 61:935-939.
66. Schoch C, Rieder H, Freund M, Hoelzer D, Riehm H, Fonatsch C (1995) Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): The implication of additional chromosomal aberrations. Ann Hematol 70:195-201.
67. Secker-Walker LM, Berger R, Fenaux P, Lai JL, Nelken B, Garson M, Michael PM, Hagemeijer A, Harrison CJ, Kaneko Y, Rubin CM (1992) Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 6:363-369.
68. Sessarego M, Frassoni F, Deffarrari R, Bacigalupo A, Miceli S, Mareni C, Ajmar F (1989) Cytogenetic follow-up after bone marrow transplantation for Philadelphia-positive chronic myeloid leukemia. Cancer Genet Cytogenet 42:253-261.
69. Shtalrid M, Talpaz M, Blick M, Romero P, Kantarjian H, Taylor K, Trujillo J, Schachner J, Gutterman JU, Kurzrock R (1988) Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: Molecular analysis, clinical characteristics, and response to therapy. J Clin Oncol 6:1569-1575.
70. Slovak ML, Traweek ST, Willman CL, Head DR, Kopecky KJ, Magenis RE, Appelbaum FR, Forman SJ (1995) Trisomy 11: An association with stem/progenitor cell immunophenotype. Br J Haematol 90:266-273.
71. Sokal JE, Gomez GA, Baccarani M, Tura S, Clarkson BD, Cervantes F, Rozman C, Carbonell F, Anger B, Heimpel H, Nissen NI, Robertson JE (1988) Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood 72:294-298.
72. Sorensen PHB, Chen CS, Smith FO, Arthur DC, Domer PH, Bernstein ID, Korsmeyer SJ, Hammond GD, Kersey JH (1994) Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 93:429-437.
73. Stanbridge EJ (1992) Functional evidence for human tumour suppressor genes: Chromosome and molecular genetic studies. Cancer Surveys 12:5-24.
74. Swirsky DM, Li YS, Matthews JG, Flemans RJ, Rees JKH, Hayhoe FGJ (1984) 8;21 Translocation in acute granulocytic leukaemia: Cytological, cytochemical and clinical features. Br J Haematol 56:199-213.
75. Uike N, Inazawa J, Nishigaki H, Takahira H, Katsuno M, Hashimoto M, Kozuru M (1991) Missing Y chromosome in Ph1-negative chronic myeloid leukemia with bcr rearrangement. Evidence for a bcr-abl recombination on chromosome 22 by in situ hybridization. Acta Haematol 85:51-55.
76. van der Plas DC, Hermans ABC, Soekarman D, Smit EME, de Klein A, Smadja N, Alimena G, Goudsmit R, Grosveld G, Hagemeijer A (1989) Cytogenetic and molecular analysis in Philadelphia negative CML. Blood 73:1038-1044.
77. Weinberg RA (1989) Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49:3713-3721.
78. Whang-Peng J, Knutsen T, Jaffe ES, Steinberg SM, Raffeld M, Zhao WP, Duffey P, Condron K, Yano T, Longo DL (1995) Sequential analysis of 43 patients with non-Hodgkin's lymphoma: Clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood 85:203-216.
79. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M (1987) Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med 316:79-84.